This competing renewal application seeks to continue and enhance the OHSU BIRCWH program entitled "Oregon BIRCWH: Scholars in Women's Health Research Across the Lifespan." Our overarching goal is to create a stimulating and nurturing environment for junior faculty to develop into leading interdisciplinary research scientists in women's health;we plan to maintain four scholars/year. Over the last two grant cycles, the Oregon BIRCWH has trained a diverse cadre of researchers who advance basic, biomedical, behavioral, and translational research in women's health across the lifespan. OHSU provides a resource-rich environment whose culture promotes interdisciplinary team science. The Oregon BIRCWH has been successful with scholars receiving approximately $40 million dollars in research funding, publishing over 200 publications, and assuming national leadership positions. The BIRCWH is the only K12 career development program at OHSU specifically dedicated to career development in women's health research. The institution is deeply committed to the BIRCWH, providing each scholar up to 50 hours of statistical support, tuition free education through the Human Investigations Program, and direct financial contributions to support their research. We will continue the existing best practices that have made our program highly successful. In this renewal we expand the centers, institutes, and mentors affiliated with the BIRCWH to address all 6 high priority NIH ORWH research goals and propose the following innovative expansions to: I) Develop and promote best practices in mentoring interdisciplinary scientists by: a) providing formal mentorship training, b) conducting a national BIRCWH survey to identify successful practices in mentoring interdisciplinary scientists, c) developing and testig tools to support the mentor-mentee relationship locally and d) disseminate best practices (lessons and tools) for mentoring nationally;and II) Catalyze the development of women's health research leaders at the institutional, state, and national level by: a) developing core competencies in women's health research that incorporate the NIH ORWH research priorities to better define the research needs of the field and target educational research training programs, b) providing formal leadership training to promote effectiveness of the next generation of women's health research leaders, c) disseminating competencies and expanding interdisciplinary research in women's health through a Statewide Annual Women's Health Research Conference, and d) formalizing a program to promote inter-institutional BIRCWH collaborations to advance women's health research and further programmatic excellence at a national level. The Oregon BIRCWH is dedicated to training the next generation of leaders in women's health research whose discoveries improve the health of girls, women, and populations. We are pleased with our program's and scholars'successes and are excited about the opportunities in this renewal to increasingly contribute at a national and programmatic level.
The Oregon BIRCWH program recruits, trains, and mentors promising junior faculty to become leaders in women's health research who improve the health of girls, women, and populations. The 16 BIRCWH scholars (11 graduates) have received almost $40 million in funding (over $23 million as principal investigator or co- principal investigator), published over 200 articles, and have assumed national leadership positions since being appointed to the BIRCWH. We build on our best practices and strong foundation to advance new initiatives incorporating NIH ORWH research priorities and expand our reach to deepen our contributions to the BIRCWH program on state and national levels.
|DuBois, Barent N; Atrio, Jessica; Stanczyk, Frank Z et al. (2015) Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy. Contraception 91:71-5|
|Enninga, Elizabeth Ann L; Nevala, Wendy K; Creedon, Douglas J et al. (2015) Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol 73:251-62|
|Lee, Christopher S; Chien, Christopher V; Bidwell, Julie T et al. (2014) Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample. BMC Cardiovasc Disord 14:73|
|Cherala, Ganesh; Pearson, Jacob; Maslen, Cheryl et al. (2014) An ethinyl estradiol-levonorgestrel containing oral contraceptive does not alter cytochrome P4502C9 in vivo activity. Drug Metab Dispos 42:323-5|
|Edelman, Alison B; Cherala, Ganesh; Munar, Myrna Y et al. (2014) Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial. Contraception 90:550-6|
|Enninga, Elizabeth Ann L; Holtan, Shernan G; Creedon, Douglas J et al. (2014) Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma. Mayo Clin Proc 89:520-35|
|Leclair, Catherine M L; Leeborg, Nicky J; Jacobson-Dunlop, Erick et al. (2014) CD4-positive T-cell recruitment in primary-provoked localized vulvodynia: potential insights into disease triggers. J Low Genit Tract Dis 18:195-201|
|Hooper, Jody E; Hebert, Jessica F; Schilling, Amy et al. (2014) Hybrid Capture 2 is as Effective as PCR Testing for High-risk Human Papillomavirus in Head and Neck Cancers. Diagn Mol Pathol :|
|Holtan, Shernan G; Pasquini, Marcelo; Weisdorf, Daniel J (2014) Acute graft-versus-host disease: a bench-to-bedside update. Blood 124:363-73|
|Eden, Karen B; Perrin, Nancy A; Vesco, Kimberly K et al. (2014) A randomized comparative trial of two decision tools for pregnant women with prior cesareans. J Obstet Gynecol Neonatal Nurs 43:568-79|
Showing the most recent 10 out of 37 publications